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INTRODUCTION. 
THE experimental investigation of resistance to cancer may be pursued 
along two lines-homologous and heterologous immunity reactions. 
A previous paper " On Sarcoma Immunity in Mice " (1 9 1 5  39) dealt 
entirely with the phenomena of homologous resistance. The present 
communication is concerned with the phenomena of heterologous 
resistance as exemplified in the reactions of the 8era of animals 
immunised with transplanted new growths from alien species. 
Although the properties of such immune sera may be described 
generally as cytotoxic, the methods employed to study them have 
mainly been developed along bacteriologica,l lines. The serum 
reactions examined are-hEmolysis, hemagglutination, complement 
fixation, precipitins, and cytolysis semu stkto.  
Anatomical and histological investigations have revealed only 
unimportant differences between the tumours of man and animals, 
whereas biological studies have proved the existence of fundamental 
distinctions involving the necessary conditions of growth of the 
neoplasms of each species. A combined application of the serum 
reactions mentioned may be expected to afford still more insight into 
the interrelation of host and tumour. The methods are particularly 
applicable to the study of tumours from one species growing tempor- 
arily in a host belonging to a different species as, eg. ,  mouse and rat 
tumours growing in chick embryos (J. B. Murphy, 1914 l) and 
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niouse tumours growing in baby rats-I?. Ehrlich (1906 2, and W. E. 
Bullock (1915 y). Experiments were also performed to see if sero- 
logical differences obtain between the different tumours of the same 
species. A large amount of transplanted rat sarcoma being available 
in the laboratory, rabbits were immunised with it, and the serum com- 
pared with the rabbit anti-mouse immune sera. 
In addition, a series of experiments was carried out to provide a 
basis for comparison with homologous cancer immunity. These were 
-(a) Immunising rabbits with watery extract of mouse tumour instead 
of intact tumour cells. For homologous resistance intact cells are 
necessary. ( b )  Using mouse embryo as antigen for heterologous 
immunity, mouse embryo being a convenient antigen for homologous 
resistance. (c) Studying the reactions of the sera of baby rats in 
which mouse tumour had grown for a time and been absorbed. 
I. IMMUNISING METHODS. 
In the first instance, the immunising material was obtained by 
transplanting into mice and also into baby rats the mouse tumours, 
carcinoma 63 and sarcoma 37p used for the earlier work on homo- 
logous resistance. Later, the observations were repeated with other 
strains, carcinoma 199 and sarcoma 37s. A useful comparison was 
obtained by immunising with rat sarcoma R16. The animals 
immunised were young rabbits varying in weight between 1000  and 
1500 grms. The tumours, aged from twelve days to three weeks 
according to the rate of growth, were removed aseptically, freed from 
macroscopically necrotic and hzmorrhagic areas, and without any 
addition minced to a fine emulsion with sharp scissors. The elaborate 
methods of preparation adopted by Forssmanii, Morgenroth, and others 
with the object of obtaining organ or tumour parenchymata free from 
blood and connective tissue are largely illusory. Complete freedom 
from blood cannot be achieved in the case of tumours even by washing 
out the vessels with salt solution, atid the connective-tissue stroma is 
so delicate and so intimately associated with the parenchyma that only 
the largest trabeculae can be separated from the tumour cells by the 
methods employed. 
The injections were made intraperitoneally and repeated at  intervals 
of seven days in ascending doses. Four injections in all were given, 
the doses being 1, 2, 4, and 5 C.C. Before each injection the rabbits 
were weighed and their temperatures taken. If loss of weight or rise 
in temperature had occurred the injection was postponed till recovery 
had taken place. In  some cases the injections were not borne well, 
temporary malaise being produced: some of the animals died in the 
course of the immunisation. Consequently it 'is rather difficult to 
immunise very highly, but with the disposition described a relatively 
high degree of immunity could be obtained. Eight days after the 
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last injection the  ariiiiials were bled froiii the carotid under an 
anzesthetic. 
The peritoneal lymph glands were always found to be much 
enlarged, to the size of a hen's egg, and filled with sterile, completely 
degenerated caseous material. 
11. HADIOLYTTC EEACTIOX. 
The hteuiolytic action of the sera of men and animals bearing 
tuiiiours has been studied by many authors. 
Thus Kelling (1906 4) studied the hsmolytic action of human cancer sera. 
on the erythrocytes of various animals, and Maragliano (1892 j) the action on 
human erythrocytes. The gestric juice from cases of stomach cancer was 
examined for hsmolysins by Grafe and Roehmer (1908G)), while tumour 
extract was studied in the same way by Kullman (1904 7). Fischel (1908s) 
summarises the results obtained by different investigators as follows. The 
serum of cancer patients shows increased haniolytic power in about 5 0  per 
cent. of cases both on the erythrocytes of the same and different species. The 
reaction is not specific for cancer since it is also found i n  other diseases, e.g., 
tuberculosis, pernicious anzemia, etc. 
The researches of Forssmann and Morgenroth bear more directly on the  
present investigations. I n  191 1, Forssmann (g) discovered that a hamolysin 
for sheep erythrocytes could be obtained bg immunising rabbits with 
emulsions of organs of the guinea-pig. Even when the hemolytic power on 
sheep's corpuscles had attained a high degree, no hamolysin for guinea-pig 
corpuscles was obtained. Two years later, Morgenroth (1913 10, 1915 lo&) 
obtained a hzmolytic amboceptor for goat corpuscles by immunising rabbits 
against mouse kidney. I n  the same way he obtained the haemolysis of goat 
erythrocytes with the serum of rabbits inoculated with transplantable mouse 
carcinoma. I n  the later paper Morgenroth and Bieling (1915 loa) published a 
fuller account of their researches. Rabbits irnmunised with mouse kidney and 
with one strain of mouse carcinoma gave sera hsmolytic for goat erythrocytes, 
but not for those of the ox and the mouse. The hsmolytic amboceptor of the 
kidney antiserum was fixed by both kidney and tumour emulsions, but more 
strongly by the kidney. The amboceptor of the tumour antiserum was 
usually fixed more energetically by tumour emulsion than by kidney emulsion. 
The authors concluded that the antigenic substances in kidney and tumour 
were in part common to both, in part distinct. 
In the  present researches these results of Forssniann a n d  
Morgenroth have been confirlned and  extended by experiments with 
tile sera of rabbits immunisecl against mouse and  rat tumours. In  
addition to goat corpuscles, those of t he  niouse and rat have also been 
employed with interesting results. 
Afithods. 
The immune sera were inactivated by heating for half an hour at 56" C. 
The complement used in the experiments was 0.5 C.C. of a 1 in 10 dilution of 
fresh guinea-pig serum, the absolute quantity of fresh serum in each tube 
being thus 0.05 C.C. For comparison, rabbit, rat, mouse, and goat comple- 
ments were also employed. The erythrocyte suspensions used were from the 
mouse, rat, goat, rabbit, and guinea-pig, the principal experiments being per- 
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formed with mouse corpuscles. To obtain the mouse corpuscles a number of 
mice were decapitated with scissors in deep ether narcosis, the blood collected 
and defibrinated by stirring with a sterile wire brush. The defibrinated 
blood was centrifuged and washed with normal saline three times, and a 
5 per cent. suspension in normal saline made from the corpuscles deposited. 
Of this suspension 0.5 C.C. was taken for each tube. The test tubes were kept 
in an incubator at 37" C. for two hours, and then placed in the ice-chest till the 
following morning. After this interval the result was noted, the degrees of 
hsmolysis being distinguished as follows : complete, nearly complete, marked, 
slight, trace, and none. 
lhyerimentnl Observations. 
The investigations of Forssniaiin and Morgenroth already referred 
to reveal a departure from the specific character of immunity reactions 
till then unsuspected in the hsemolysins. Thus in Forssniann's experi- 
ments the serum of the rabbit immunised with organ-emulsions of the 
guinea-pig while strongly hamolytic for sheep's corpuscles was without 
action on the corpuscles of the guinea-pig. Morgenroth stated that 
his immune sera, strongly hzmolytic for goat corpuscles, were without 
action on the erythrocytes of the mouse, the animal from which the 
organ and turnour emulsions used by him as antigens were obtained. 
The experiments now to be described show that this discrepancy is 
only apparent, since the immune sera obtained from rabbits injected 
with mouse-tumour emulsions are hzmoly tic for mouse erythrocytes, 
as might have been expected from general considerations. The 
hzniolytic immune body for goat erythrocytes will be shown to be 
distinct, and, as it were, superadded to the hzmolytic amboceptor 
specific to the mouse. 
At the same time experimeiits were carried out to ascertain 
whether the fresh sera of the rabbit, rat, and mouse were able to 
complement the immune body in the same way as that of the guinea- 
pig. The immune sera were those from rabbits repeatedly injected 
with eniulsions of mouse carcinoma 63 and mouse sarcoma 37p. It 
is to be noted that neither the highest testing dose of inactivated 
immune serum, namely, 0.1 c.c., nor 0.05 C.C. of the fresh sera used as 
complements, of themselves caused hEmolysie of mouse corpuscles. 
Inactivated normal rabbit serum 0.1 c.c., with the addition of 0.05 C.C. 
fresh guinea-pig serum as complement was without action on the 
corpuscles of the mouse, rtlt, guinea-pig, and goat. 
The experiments (Tables I. and 11.) demonstrate clearly that the 
sera of rabbits immunised with mouse tuniours, carcinoma and sarcoma, 
are strongly hmnolytic for mouse corpusclea. Guinea-pig complement 
is seen to be most erective, while those of the mouse and rat are 
inert in the dose employed. The behav-iour of rabbit complement is 
not the same with the two antiaera; while inactive in combination 
with the sarcoma serum, it is able to  produce marked hsemolysis with 
the carcinoma serum. This difference indicates that the hemolytic 
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amboceptors in the carcinoma and samoma antisera are not quite 
identical. The experiment was repeated with two other sera obtained 
by immunising with sarcoma 37s and carcinoma 199, and a very 
similar result obtained, the only difference being a slight degree of 
hemolysis with the sarcoma antiserum in this caee. 
TABLE I.-Hcemolysis of Nouse Blood Corpuscles by Mouse Sarcoma (37 p) 
Antiserum, using Various Complements. 
MOUSE BLOOD COKPUSCLES. 
- 
- 
1 
2 
3 
4 
5 
6 
7 
- 
37 P 
Antiserum. 
0.1 
0.05 
0’025 
0’01 
0.005 
0.0025 
0’001 
Guinea-pig 
Complement, 
0’05 C.C. 
Complete. 
Rabbit 
Complement, 
0’05 C.C. 
~ _ _ _  
None. 
1 
Nearly complete. 
Sligli t . 
I 
I 
Trace. ~ 
Rat 
Complement, 
0.05 C.C. 
None. 
,, 
, 
,, 
Monse 
Complement. 
0‘05 c.e. 
None. 
, 
, 
TABLE &--Hc~niolysis of Mouse Blood Corpuscles by Mouse Carcinoma 
(63) Antiserum, using Various Complements. 
.- 
-. 
1 
2 
3 
4 
5 
6 
i 
MOUSE BLOOD COEPUSCLES. 
63 
bntiserum. 
0’1 
0‘05 
0’025 
0 ‘01 
0’006 
0’0025 
Guinea-pig 
Complemeiit, 
0‘05 C.C. 
Complete. 
Rabbit ~ Rat 
0.05 C.C. 
Complemeiit, 1 Co;;fr;,nt, 
~ _~ 
I 
Marked. None. 
Slight. 
Nearly complete. Nearly complete. 
Slight. None. 
Trace. 
Nolie. I ” 
,, 
, 
, 
I ” I ” 0’001 I ,, 
Mouse 
Coruplenient , 
0‘05 C.C. 
None. 
In  view of the results obtained in the study of hlood relationship 
by the hzmolytic method, it is interesting to study the action of these 
anti-mouse sera on the red blood cells of the closely related rat. 
Tables 111. and 1V. give the results of two of these experiments. 
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I Guinea-pig 63 Antiserum. Complement, 
0'05 C.C. I 
- _ _ _  - 
1 . .  0 '1 Slight. 
2 . .  0.05 Trace. 
0.025 None. 
I 
4 . . ~ 0.01 , 
7 ,  
0.0025 3 ,  
0.001 # 
TABLE III.-Ecemolyais of Rut Blood Corpuscles by Mouse Sarcoma (37 p) 
Antiserum, wing Guinea-pig and Rabbit Complement. 
Rabbit 0'05 Comp1ement3 C.C. 
None. 
,, 
,t  
* I  
3 3  
, l  
, 
1 . .  
2 . .  
3 . .  
4 . .  
5 . .  
6 . .  
7 . .  
RAT BLOOD CORPUSCLES. 
37p Antiserum. 
0.1 
0'05 
0'025 
0.01 
0.005 
0'0025 
0'001 
Guinea-pig 
Complement, 
0'05 C.C. 
Nearly complete. 
Marked. 
Slight. 
None. 
,, 
I *  
9 ,  
Rabbit Complement, 
0.05 C.C. 
TABLE IV.-HemoHy&s of Rat Blood Corpuscles by Mouse Carcinoma (63) 
Antiserum, wing Guinea-pig and Rabbit Complement. 
I RAT BLOOD CORPUSCLES. 
The experiments demonstrate a much feebler action of the sarcoma 
serum on rat corpuscles than on those of the mouse, and in the case 
of the carcinoma serum the action is still less evident. The same 
result was obtained in the experiment with two other antisera, against 
sarcoma 37s and carcinoma 199. As in the experiments with mouse 
corpuscles, guinea-pig complement is much more active than rabbit 
complement, the dose of the latter used being quite incapable of 
producing haemolysis. The sera are thus seen to be specific to a 
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considerable degree, doses which still produce marked hzmolysis of 
mouse corpuscles being without action on the corpuscles of the rat. 
When these antisera are tested for hEmolytic activity against goat 
blood corpuscles a very striking contrast is shown. The result of 
such an experiment is seen in Tables V. and VI. 
TABLE v.-~umolysis of Goat Blood Corpuscles by kfouse sarcoma 
(37 p) Antiserum 
GOAT BLOOD C o a ~ u s c ~ s s .  
- - _  
37 p Antiseiuni. 
. - ~~~ 
1 . .  . 
2 . .  . 
3 . .  . 
4 . .  . 
5 . .  . 
6 . .  . 
7 . .  . 
0 '1 
0.05 
0.025 
0.01 
0.005 
0'0025 
0'001 
Guinea-pig 
Complement, 
0'05 C.C. 
Complete. 
I ,  
,, 
Nearly complete. 
Marked. 
Slight. 
TABLE V'I.--Hcemolytic Reaction qf Goat Blood Corpuscles by Mouse 
Carcinoma (63 p) Antiseium. 
Guinea-pig 
~ 63 Antiserum. Complement, 
0.05 C.C. 
_____  - 
1 . .  . 0'1 , Complete. 
2 . . . I 0'05 I 
3 . .  . 1 0.025 >, 
1 4 . .  0.01 Marked. 
6 . .  . I 0.0025 1 Trace. 
5 . . : i 0'005 
7 .  . . I  0 001 ' None. 
I _____ . 
Hzmolysis is obtained with both sera (sarcoma and carcinoma) to 
As the same degree as in the experiments with mouse erythrocytes. 
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I 
Ordinary 1 Amboceptors. 
I __ 1 .  . . I 0.01 
2 .  . . I  0.005 
in those experiments (cf. Tables I. and II.), the 37p antiseruni is 
rather more potent than the serum against carcinoma 63. Taken in 
Conjunction with the experiments on rat  erythrocytes the experiments 
with goat corpuscles are sufficiently remarkable, for they seem to belie 
the evidence of specificity in the experiments with the blood cells of 
the mouse and rat. Experiments were therefore undertaken in the 
first place with erythrocytes of other species, namely, rabbit and 
guinea-pig. It is unnecessary to give tables of these experiments as 
they failed to give a positive result, although the first tube of sarcoma 
antiserum (0.1 c.c.) caused slight hzmolysis of guinea-pig corpuscles. 
The antibody, therefore, which hzmolyses goat corpuscles is not active 
on red blood corpuscles generally, and the conclusion cannot be drawn, 
from the experiments so far described, that the lysis of mouse 
corpuscles by these antisera is not due to a specific hemolysin. 
Before passing to experinients designed to elucidate the relation of 
the agents in these sera responsible for hiemolysis of mouse and goat 
corpuscles respectively, i t  is instructive to test the effect on mouse and 
rat erythrocytes of a hEmolysin for goat corpuscles obtained in the 
ordinary way by immunising rabbits with goat’s blood (Table VII.). 
Guinea-pig 
Complement. 
0‘05 c. c. 
TABLE VII.-The Behaviour of Odinary H m i o l y t i c  Amhocepfors on 
Mouse and Rat  Blood CorpuscTes. 
OnMouse OnRat  
Erythrocytes. I Erythrocytes. 
I 
I - - -  - ___ 
None. None. 
iVote.-O‘0005 C.C. of this hsmolysin causes a complete hzmolysis of 5 per cent. 
goat blood corpuscles suspension (0 ’5 c.c.). 
The experiment shows that the goat hemolysin is without action 
on mouse or rat corpuscles even in a concentration seventy times the 
minimal hzmolytic dose for goat corpuscles. Hence the action of the 
hzmolysin produced by mouse tumour as antigen is not due to 
identity of the lysinogens for mouse and goat erythrocytes, and the 
antibodies in the tumour antisera which dissolve mouse and goat 
corpuscles respectively cannot be the same. To test the validity of 
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-- 1- -- - 
I Z &  
I 8 2 
sb a- 
I %: 
ge z - - - _ _ _ _ _ 1  
1 0'1 
2 0'05 
3 0.025 
TABLE VlII. (a).--Hcenzolysis of Mouse Blood Cells by the Super?tatant 
Fluid of Mouse Sarcoma (37 p) Serum, after Treatment with 10 per cent. 
1 
~ - _ _ _  
Y 
25 ~ 1 c.c. Supernatant 
$= Fluid=Original :; 1 Serum. 
%; 
2 1  
_______ 
C.C. 
,, bD 
,, j .d gs c2s 
& 
E 
8;  
C.C. 
=0'05 
=0.025 
= 0.01 
=0'005 
=0'0025 
=0*001 
- -  
- -- 
* 
z 
C.C. 
0'05 
,, 
I ,  
, 9  
9 ,  
, 
Complete. 
, t  
Marked. 
Slight. 
Trace. 
None. 
Complete. 
, f  
,, 
Marked. 
Slight. 
Trace. 
None. 
TABLE VIII. (b).-Hcenzol:ysis oj* Mouse Blood Corpuscles b y  the Supernatant 
Huid of Mouse Carcanonza (63) Serum, ajter Treatmeid with 10 per cent. 
Goat Blood Corpuscles. 
1 
2 
3 
4 
5 
6 
7 
=0'0!25 
=0*01 
= 0'005 
= 0'0025 
=0*001 
Complete. 
9 ,  
Slight. 
Trace. 
None. 
>, 
, 
Cont,rol 
(without 
Treatment). 
Complete. 
,, 
Slight. 
Trace. 
None. 
f 
this conclusion the following experiment was performed. Goat 
corpuscles were sensitised for two hours in the incubator a t  37" C., 
with mouse-turnour haemolysiri in the proportions: 1 C.C. of 1 0  per 
cent. suspension of washed goat corpuscles to 0.1 C.C. of immune 
serum. The tubes were then centrifuged and the ha?molytic reaction 
carried out with the supernatant fluid on mouse erythrocytes. If the 
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hremolysis of mouse and goat corpuscles by the mouse-tumour antisera 
were due to the same antibody, it would all be fixed by the goat 
corpuscles, and the supernatant fluid would be devoid of hremolytic 
action on mouse corpuscles (Table VIII. (a) and (b)). 
The experiment clearly demonstrates that the supernatant fluid 
contains the hamolysin for mouse corpuscles in undiminished strength, 
as compared with the untreated serum. At  the same time the 
sensitised goat corpuscles were again suspended in fresh normal saline, 
and, with the addition of guinea-pig complement, incubated for two 
hours in the ordinary way. 
TABLE IX.-Hmnolyeis of the Sediment, i.e., Goat Blood Coipuscles 
sensitised roitli Mouse Sarcoma (37 p> Sei-zcna for two hours. 
_ _ ~ ~ ~  
1 .  . 
2 .  . 
3 .  . 
4 .  . 
5 .  . 
6 .  . 
7 .  . 
0'1 
0 -05 
0'025 
0'01 
0'005 
0'0025 
0.001 
C.C. 
1 ' 0  
, 
I ,  
$ 9  
3 ,  
Half Portion of 
Sediment= 
Original Serum. 
- 
C.C. 
=O'O5 
= 0'025 
=0*01 
=0'005 
=0*0025 
=0.001 
- 
C.C. 
0 '05 
,> 
, 7  
, 
9 
, I  
-__ 
Complete. 
Slight. 
Trace. 
None. 
- 
Control 
(without 
.TRatmmt). 
. . . . 
Complete. 
t 
9 
Slight. 
Trace. 
None. 
The result is shown in Table IX., and it is seen that the hzmolysin 
has fixed itself to the goat corpuscles, so that hzemolysis is produced 
to the same degree as in the experiment with the original serum 
(cf. Tables V. and VI.). The experiments prove that two separate 
hamolysins co-exist in the mouse-tumour antisera, one which is fixed 
specifically by mouse red cells, the other by goat red cells. The 
experiments further show that these two hzemolytic amboceptors 
produced simultaneously are present in practically the same strength, 
which, unless a coincidence, considerably enhances the difficulty of 
finding a satisfactory explanation for the phenomenon. The problem 
is simply that of the nature of lysinogens generally. Many authors 
believe they are of a lipoid nature (Bang and Forssniann, 1 9 09 ,19  10  11) 
or a combination of lipoid and protein (Landsteiner, 1909 12). The 
most obvious conclusion seems to be that mouse tissues (and mouse 
tumours) contain lysinogens capable of gil-ing rise in the rabbit to 
hzmolytic amboceptors for mouse and goat blood corpuscles sininl- 
taneously . 
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There is another problem which can be approached by means of 
hzemolytic reactions, namely, the relation which obtains between a 
tumour and its host when growing teniporarily in an animal of alien 
species, in respect of the estent to which the tissue proteins retain 
their specific identity under these conditions. As has frequently been 
pointed out, no difference can be detected histologically between the 
cells of tuniours growing in the maternal soil and in alien soil. Since 
mouse tumours can be grown in incubating hen eggs and in rats, a 
variety of dispositions are available for this purpose. Ehrlich (1906 2, 
was the first to point out the possibility of obtaining temporary growth 
of transplantable mouse tumouis in rats. He says: “Impft man 
dagegen eine Eatte mit einen nnserer Sarkome, so sieht inan schon in 
den allerersten Tagen einen schnell wuchernden Tumor eich bilden, der 
bis ungefahr Luni 6. Tage zunimmt. Zu clieser Zeit bietet die Ge- 
scfiwulst ein sehr charakteristisches Aussehen. Der nieist Iang ges- 
treckte wurstforniige Tumor fubilt sich derb an und besteht aus einern 
machtigen Gcschwulstmantel, der sackformig den Rest der nekrotischen 
Impfmassen nmschliesst. Histologisch ist weder im Form und Anord- 
nung der Zelleii, noch in dem Reichtnm an Mitosen ein irgendwie 
nennenswerter Unterschied gegeniiber eineni gleichaltrigen Mausetumor 
nachzuweisen. duch das Careinom ist, obwohl in beschranktem 
Masse, filhig, im Rattenorganisnius znnhchst z u  wnchern, und das 
gleiche gilt von kiiristlichen Miscliungen von Carcinom und Sarkom.” 
A much more uniform and longer continued growth is obtained, as 
Bullock ( 19 15  3, has shown, when mouse tumours are inoculated into 
new-born rats and success is obtained with carcinomata as well as 
s;trcomata. This method was therefore adopted for the present in- 
vestigation. and the material for immunisation taken from baby rats 
in which the same mouse tumours (sarcoma 37p and carcinoma 63) 
had been inocnlated and were still growing rapidly. Bullock @) showed 
that although continuous propagation of mouse tumours coulcl be 
obtained in rats by repeated transference to fresh new-born rats while 
active growth was still progressing, nevertheless the tumours did not 
acquire the ability to grow progressively in the rat, nor lose their 
powers of growth in the original soil of the mouse. The tuniours 
remained mouse tumours in spite of a lengthy sojourn in alien soil. 
It was hoped by killing the baby rats a t  from seven to ten days 
after inoculation and removing all hzniorrhagic and necrotic areas to 
obtain the tumour parenchyma relatively free from rat erythrocytes, 
m y  considerable admixture of which would introduce an obvious 
difficulty in interpreting the results. 
The experiments (Table X.) show a distinct increase in the 
hmiolytic action on rat corpuscles, as compared with the sera derived 
froiri mouse tumours growing in mice. The sera are still strongly 
h:emolytic for mouse corpuscles, but not quite equal to those first 
stndietl. In view of the necessary admixture of rat tissue, stronia, and 
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TABLE X.-Hwnolytic Analysis of Mouse Tunzour (Sarcoma 37 p) gvozun 
in Mice a d  in Baby Rats under same Conditions. 
1 .  . . 
2 .  . . 
3 .  . . 
4 .  . . 
5 .  . . 
6 .  . . 
7 .  . . 
HBMOLSSIS OF MOUSE BLOOD COKPUSCLES. 
Mouse Sarcoma 
(37p) Serum. 
0.1 
0.05 
0.025 
0'01 
0.005 
0-0025 
0'001 
Guinea-pig 
Coniplement, 
0'05 C.C. 
Complete. 
,> 
,, 
Nearly complete. 
Slight. 
Trace. 
1 .  . . 
2 .  . . 
3 .  . . 
4 .  . . 
5 .  . . 
37p (from Baby 
Rat) Serum. 
0 '1 
0.05 
0.025 
0.01 
0'005 
0'0025 
0.001 
HBMOLTSIS OF RAT BLOOD COI:PUSCLES. 
0'1 
0'05 
0.025 
0.01 
0'005 
0'0025 
* I  
. I  
6 .  . 
7 .  . ' 0'001 
Nearly complete 
Marked 
Trace. 
None. 
Guinea-pig 
Complement, 
0'05 C.C. 
Complete. 
,* 
, I  
Nearly complete. 
Slight. 
Trace. 
None. 
0 '1 
0.05 
0'025 
0'01 
0.008 
0.0025 
0.001 
Complete. 
, I  
Marked. 
Sliglr t. 
Trace. 
None. 
blood, in the tumours growing in rats, this result is probably as good 
as could be expected. It does not permit the conclusion that the 
mouse-tumour parenchyma has acquired specific rat characteristics as 
a consequence of its temporary dependence on the rat organism for 
nourishment. The same result was obtained with carcinoma 63 grown 
in baby rats. The fact that hzeinolysis of mouse corpuscles was 
obtained with the antisera against mouse tumours grown in rats, 
shons that the hemolysins in these experiments are noC produced in 
consequence of the presence of blood in the immunising emulsions. 
No mouse blood or connective tissue is present in the emulsion of 
mouse tumour grown in rats, these being supplied by the host. The 
experiments with rat-tumour (R 16) antiserum show that rat tissue does 
not give rise to any very powerful mouse hamolysin. The mouse 
heinolysin in the antiserum against niouse tumours grown in rats 
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must therefore owe its origin to the mouse parenchyma injected. As 
a consequence an antigenic rBle must be ascribed to the parenchyma 
of mouse tumours grown in mice, in the production of the mouse 
hxmolysins obtained. 
While these experiments were in progress, a spontaneous rat 
satcoma was obtained which grew progressively in all  the normal 
animals inoculated. The opportunity thus provided was seized to 
immunise rabbits with this sarcoma R 16, for comparison with the 
anti-mouse sera. The principal experiments only were repeated with 
this anti-rat serum, and some of these experiments are given in 
Tables XI., XlI., XIII. 
TABLE SI.--Hmnolysis of’ Rat Blood Coryuscles by Rat Sarcoma 
(R 16) Antiserum. 
i RAT BLOOD CORPUSCLES. 
Guinea-pig ~ Rabbit 
0.05 C.C. 0’05 C.C. 
R 16 Ailtiserum. Complement, Complement, 
I 
1 .  . . 0 ’1 Complete. l Complete. . I 
2 .  . . 0-05 ,, ~ Nearly complete. 
3 .  . . 0‘025 Nearly complete. I > 
1 4 .  . . 0’01 Marked. Slight. 
I s .  . . 0‘005 Slight. I I Trace. 
6 .  . . 0’0025 None. None. 
7 .  . . 0’001 > >  > >  
The tables show that the immune serum contains a hzmolysin for 
rat erythrocytes similar to that for mouse erythrocytes in the anti- 
mouse tumour sera. The anti-rat serum, however, is not haemolytic 
for mouse corpuscles. It  is to be noted, however, that the anti-mouse 
sera were much more potent, hzmolysis being complete even with 
0.01 C.C. of antiserum, whereas 0.05 C.C. is the smallest dose of anti- 
rat serum capable of producing complete hemolysis of rat red cells. 
Rabbit complement, again, is able to produce lysis with the anti-rat 
serum, the corresponding experiment with mmse erythrocytes and 
antiserum being negative (see Table I.). The action on goat corpuscles 
also was feebler than that exhibited by the mouse-tumour antisera, in 
which, as already noted, a goat hzmolysin is present to the same 
degree as the mouse haemolysin. 
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_ _  i--- I 1 
1 
~ 1 R 16 Antiserum. 
1 .  . . I  0.1 
2 . . . 1 0.05 
3 .  . . 0'025 
4 .  . . ' 0.01 
5 .  . . 0'005 
6 .  , . 0 0025 
7 .  * . 0.001 
TABLE XII.-Hmmolysis of Mouse Blood Corpuscles by B 16 Antiserum 
__ 
Guinea-pig Rabbit 
Complement, Complement, 
0'05 C.C. 0.05 C.C. 
Marked. None. 
,, > l  
Slight. 9 
Trace. 9 ,  
None. 
3 ,  
,, 
MOUSE BLOOD CORPUSCLES. I 
R 16 Antiseruni. 
I 
0.1 
0.05 2 .  * . * . 1 
. . . 1 0.025 
4 . . . 1 0.01 
5 . . . 1 0.005 
0.0025 
Guinea-pig 
Complement, 
0.05 C.C. 
Rabbit 
Complement, , 
0.06 C.C. ' 
The attempt has been made to utilise the resistance of the 
erythrocytes of cancer patients to hzmolysis, for the differential 
diagnosis of malignant disease. Eraga (1 9 1 0  13) assumed that cancer 
extracts are more strongly hemolytic on cancer patients' erythrocytes 
than on those of normal individuals. Kraus, Plotzl, Ranzi, and H. 
Ehrlich (1909 studied the resistance of the erythrocytes of cancer 
patients and animals to  cobra venom. They found increased hsmo- 
lysis of the red cells of sarcoma-bearing rats, and decreased haeinolysis 
on those of carcinoma-bearing mice. They also obtained a similar 
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result in the human subject. The attempt was niade to see whether 
similar differences in susceptibility to the specific mouse hzmolysin 
produced by immunisation could be detected between the erythrocytes 
of inice bearing transplanted tumours and those of normal healthy 
animals. Tables of these experiments are not given since no such 
differences could be detected. 
S u m n a ~ y .  
1. By iinmunising rabbits against mouse tumours, antisera are 
obtained hemolytic for mouse eryt,hrocytes. 
2. The sera are equally hemolytic for goat erythrocytes, but the 
two aniboceptors are distinct and can be separated by absorption of 
one of them by the corresponding erythrocyte suspension, the other 
amboceptor remaining in undiniinished strength. 
3. The anti-mouse tuiiiour sera also hEmolyse rat  blood corpuscles, 
but to a much less degree than mouse and goat corpuscles, 
4. When moiise tumours inoculated into new-born rats are used 
to inimunise rabbits, antisera are obtained which are nearly as strongly 
hzmolytic for rat erythrocytes as for iiiouse erythrocytes. 
5. The complement used in all the principal experiments was 
fresh guinea-pig serum. Rabbit complement was without effect on 
mouse erythrocytes in combination with the mouse sarcoma (37p and 
37 s) antisera, whereas definite hzemolysis was obtained with i t  in 
presence of the mouse carcinoma (199 and 63) antieera. 
6. The antiserum obtained by immunising rabbits with a rat 
sarcoma (R 16) hzmolysed rat and goat erythrocytes with both 
guinea-pig and rabbit complement, but was without action on those of 
the mouse. 
111. H~MAGGLUTINATION. 
Agglutination or clumping of red blood corpuscles by normal 
serum was described as long ago as 1869  by Creite (15) In  1898 
Bordet (1'3) showed that hzmagglutinins appeared in the serum of 
animals immunised against alien red blood cells. The hEmolysin 
produced a t  the same time can be eliminated from the experiments 
in virtue of the fact that although therniostabile (Sachs 17) like the 
hmnagglntinin, it requires the presence of fresh serum or complement 
to produce lysis. The hzemagglutinin acts without the addition of 
complement, so that if this be omitted from 'the tubes, no hzmolysis 
takes place and agglutina tivn can be studied independently. Bordet 
and Gay (1 906 Is) further showed that ox-serum normally contains 
a substance which clumps red corpuscles when fresh horse serum is 
added. To this substance the provisional designation of " colloid " 
was given by these authors, later changed to " conglutinin " by Bordet 
and Streng (1909 19) after further investigation. There is thus 
introduced a distinction between hemagglutination and conglutination, 
MALIGNANT TUMOURS OF MOUSE AND RAT 229 
the former being strictly a product of active immunisation and able 
to clump erythrocytes without the aid of complement, the latter 
occurring in the serum of untreated animals of certain species but 
only able to agglutinate corpuscles which have already been acted on 
by amboceptor and complement. The present paper deals only with 
the former, namely, immune haemagglutinins. It is to be noted that 
in the first place these were produced by injection of alien blood 
corpuscles, but Skrobansky (1903 ") has reported that the sera of 
animals immunised with ovary and corpus luteum of alien species 
agglutinated the homologous erythrocytes. It was therefore decided 
to test the sera of rabbits immunised against mouse and rat tumours 
which, as has just been shown, are strongly hzmolytic, for the 
presence of agglutinins for the red cells of these animals. 
Methods. 
The immune sera were inactivated by heating in the incubator at 56" C. 
for half an hour. The 5 per cent. suspension of red corpuscles was prepared 
in the same way as for the hamolysin experiments. To each of the test tubes 
containing falling doses of inactivated immune serum made up to 1 C.C. with 
normal saline, 0.5 C.C. of 5 per cent. erythrocyte suspension was added, and the 
tubes placed in the incubator a t  37' C .  for two hours. At the end of this 
interval the results were read macroscopically. Landsteiner and Reick 
(1905 21) contend that the reaction must be carried out at  room temperature, as 
a higher temperature disturbs the phenomenon, but in the present series of 
experiments no difference could be observed between the results under both 
conditions of temperature. In reading the results macroscopically the main 
points to observe are the speed at  which the corpuscles come down after 
shaking and their ability to pass through filter paper. It is no advantage to 
keep the tubes overnight in the ice-chest as in the case of haemolysin 
experiments, as spontaneous agglutination is apt to occur even in the control 
tubes with normal saline alone. 
+ + +  . . very distinct. 
The results are recorded as follows :- 
+ +  . . distinct. 
+ .  . positive. 
2 .  . suspiciouu. 
- . negative. 
Experime~~tal Observations. 
Progressive dilutions 1 to 20, 1 to 40, 1 to 80, etc., of each 
immune serum, were prepared with normal saline and 1 C.C. of each 
dilution placed in a test tube to which 0.5 C.C. of 5 per cent. 
suspension of mouse red blood corpuscles was added. For comparison 
and control similar tubes were prepared with suspensions of rat, 
guinea-pig, and goat corpuscles. As a general control a tube was 
prepared with each of the erythrocyte suspensions and inactivated 
normal rabbit serum diluted 1 : 20. In  this dilution rabbit serum 
does not agglutinate any of the suspensions. The experiments 
(Tables XIV., XV., XVI.) demonstrate that the immune sera against 
mouse tumours agglutinate the red corpuscles of the mouse strongly, 
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I 1 Proportion of 
j Diluted Serum. 
I 
TABLE XITT.-H~Riizngnlutination by Mouse-Tuinour Antiserunzs on Mouse 
Blood Corpusrr7e.q. 
- 
MOUSE ]%LoOD CORPUSCLES. 
5 per cent. Mouse 
Blood Corpuscles. 
640 >, ~ 
, 
1 63 (from 
Serum. 
37 p Serum. 63 Serum. Baby Rat) 
I 
+ + +  ' + + +  + + +  
+ + +  + + +  + + +  
+ +  f + + 
- - 1 -  
+ I f  - + ' Z 1 -  - 
I 
TABLE XV.-H~~,,aagglutinatioi1 by Mouse-Tunaour Antiserums on Rat 
Blood CorpuscEes. 
RAT BLOOD CORPUSCLES. 
~. -p - ._-__ - ____ 
I I 
Proportion of 5 per cent. Rat 
Dilnted Serum. Blood Corpuscles. 
- -~ -~ 
0.5 C.C. 
,, 
>, 
9 ,  
, f  
,, 
1 , . 1: 20 (1 C.C.) 
2 . . 1: 40 ,, 
3 . . 1: 80 ,, 
4 . . 1:160 ,, 1 
5 . . 1: 320 ,, , 
6 . . 1: 640 ,, 
I 
I 63 (from I 
3Pp Serum. 63 Serum. Baby Rat) 1 
Serum. I 
I 
TABLE XVI.-Hcenaagqlutination by Mouse-Tunzour Antiserums on 
Guinea-pig Blood Corpuscles. 
____ 
GUINEA-PIG BLOOD CORPUSCLES. 
- ~ 
37 p Serum. 63 Serum. Baby Rat) 1 1 re::: 
1 . . 1: 20(1 C.C.) 
2 . . , 1 :  40 ,, 
3 . . 1: 80 ,, 
4 . . 1: 160 ,, 
5 . . 1: 320 ,, 
. * " 
0.5 C.C. 
, I  
9 ,  
, 
I ,  
,, 
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no hsemagglutination taking place with any of the other suspensions, 
not even of the rat. The antiseruii prepared from mouse carcinoma 
63 p in baby rats as antigen shows instructive differences. This serum 
agglutinates rat corpuscles strongly as well as niouse corpuscles. This 
result is similar to that obtained with the same serum in the 
hamolytic experiments, and the same considerations apply to the 
interpretation of the result. The experiments were also carried out 
with mouse sarcoma (37 p) antiserum with the same result, so that it is 
unnecessary to give tables of them. The rat sarcoma (R 16) antiserum 
showed a corresponding behaviour, agglutiuating rat erythrocytes 
distinctly while only feebly agglutinative for mouse corpuscles. It 
was without action on the red cell suspensions of the guinea-pig 
and goat. 
The observations of Landsteiner (1908 ”) are not strictly com- 
parable with the results described. He  found that watery extracts 
of mouse and rat turnours agglutinate rabbit erythrocytes, and tried 
to prove a relation between hzmagglutinating power and the 
malignancy of a tumour. The immune hsmagglutinins contained in 
the sera now under investigation are in all probability quite different 
from those present in watery extracts of tumours. 
Summary. 
The immune sera obtained by injecting mouse and rat  tumours 
into rabbits, in addition to being h~!molytic, as already shown, contain 
specific agglutinins for the red blood corpuscles of the corresponding 
species. Whereas a specific hzniolysin for goat corpuscles is obtained 
by immunising with mouse and rat  tumours, the sera do not 
agglutinate goat corpuscles in the lowest dilution studied. When 
mouse tumours grown in rats are used as antigen, the agglutinative 
power for rat  erythrocytes is greatly increased, a result in all 
probability due to the admixture of rat tissue in the antigenic tumour 
emulsions. 
IV. COMPLEMENT FIXATION. 
It is unnecessary to review the large number of papers by many 
authors dealing with complement fixation in cancer, since they mostly 
deal with the subject from a totally different standpoint from that 
adopted in this paper. They have concerned themselves with the 
search for specific antibodies for cancer in the sera of men and 
animals bearing tumours, using tumour extracts and other substances 
as antigens. That subject is not yet definitely settled, for the several 
authors are not yet in agreement, soue authors claiming to have 
demonstrated the presence of specific antibodies by this method, while 
others as emphatically deny their existence. 
The problem now under consideration is that of the presence of 
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complement fixing antibodies in the sera of animals immunised against 
tumours of alien origin. Cognate studies have been carried out by 
Michaelis and Fleischmann (1 9 06 23), who immunised rabbits against 
guinea-pig and mouse-liver cells free from blood. The immune sera 
obtained fixed complement in the presence of the homologous antigens, 
namely, extracts of the livers of mouse and guinea-pig. The reaction 
was much feebler when extracts of other organs, e.g., kidney, 
spleen, and red blood corpuscles, were employed. In addition, they 
were able to separate the complement tixing antibody from the 
hemolytic amboeeptors present in the sera, and also to  prove its 
independence of any protein precipitating substance in them. Later, 
Fleischmann and Davidsohn (1 9 0 S 24) investigated complement 
fixation in immune sera also prepared against guinea-pig and mouse- 
liver cells. According to them, the reaction was positive with the 
homologous antigens, and yet was negative with normal serum, and 
also with liver extracts of other animals, as, for instance, man, ox, pig, 
rat, etc. 
There is therefore every reason to expect that the mouse- and rat- 
tumour antisera will contain complement fixing substances, and these 
sera have therefore been studied in this direction with a considerable 
variety of antigens. 
Methods. 
The immune sera were inactivated at 56" C. for half an hour. I n  addition 
to the homologous antigens, prepared from the tumours used for immunising, 
eleven organ extracts were also used for comparison. The extracts were 
prepared from healthy tumour or normal tissue, which, without any addition, 
was cut up with scissors to a fine uniform emulsion. To 1 C.C. of the 
emulsion, 5 C.C. of normal saline containing 0.5 per cent. carbolic acid was 
added, and the mixture placed in the ice-chest for two days. The fluid was 
then filtered off, and 0.2 C.C. of the filtrate used as antigen in each tube. It 
was found by experinlent that twice this quantity alone did not interfere with 
complete hsmolysis. The antigens, prepared as above, were found to remain 
active for three weeks to a month when kept in the ice-chest. Goat erythro- 
cytes and a homologous hzmolytic serum formed the hamolytic system. The 
titre of the goat hsmolysin was 0.0005 c.c., which haemolysed 0.5 C.C. of 
5 per cent. suspension of red cells completely. To prepare the goat corpusole 
suspension, bloocl was drawn by irenepuncture from a healthy male goat, 
defibrinated, and washed three tinies with normal saline as already described 
for the mouse erythrocyte suspension used in the haemolysin experiments. 
Fresh guinea-pig serum was used as complement in the majority of the experi- 
ments, but in some cases rabbit serum was also employed. The dose of 
coniplement was 0-5 C.C. of a 1 in 10 dilution,,giving an absolute dose of 0.05 C.C. 
According to the degree of hzpmolysis, the results are recorded as complete, 
nearly complete, marked, slight, trace, and none. 
Expehlental Obsewatioiu. 
An initial difficulty was caused by the presence in the mouse- 
and rat-tumour immune sera of a hzemolytic amboceptor for goat 
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corpuscles. It was found that consistent results could not he 
obtained with the untreated inactivated immune sera by using either 
goat or mouse erythrocytes in the hzmolytic system. The difficulty 
was overcome in the following manner, suggested by the haemolytic 
experiments demonstrating the independence of the two hzemolysins 
for mouse and goat corpuscles respectively (Tables VIII. and IX.). 
The serum to be tested WICS incubated for one hour with washed goat 
corpuscles, in the proportion of 1 C.C. of a 10  per cent. suspension of 
goat corpuscles to 0.1 C.C. of immune serum. At  the end of this 
period the tube was centrifuged and the complement fixation reaction 
carried out with the supernatant fluid, of which, therefore, 1 C.C. 
corresponded to 0.1 C.C. of the original serum. 
TABLE XVI1.-Complernent Pixation by Mouse Carcinonaa (199) Antiserum, 
with I-Tomologous and Heterologous Aztigens. 
199 Antiserum. 
~~ 
0'1 - * /  
. .  I 0.05 
. . 1 0.025 
. .  0.01 
. .  0.005 
. .  0.0025 
I 
I 
0.001 
Homologous 
Extract, 0'2 C.C. 
None. 
37 p Extract, 
0'2 C.C. 
____ 
None. 
, I , 
Slight. 
Marked. 
Trace. 
Slight. 
Marked. 
Complete. 
TABLE XVIIX.-~oniplenzelzt Fixation by  Mouse Sarcoma (37 s) Antiserum, 
itiith Homlogous and Heterologous Antigens. 
1 .  . . 
2 .  . . 
3 ,  . . 
4 .  . . 
5 .  . . 
6 .  . . 
7 .  , . 
37 s Antiserum. 
0'1 
0.05 
0'025 
0.01 
0'005 
0'0025 
0.001 
- _. 
Homologous 
Extract, 0.2 C.C. 
~~ _ _ _ _  
None. 
>, 
Slight. 
Marked. 
Complete. 
199 Extract, 
0.2 C.C. 
Trace. 
, 
9 
Slight. 
Marked. 
Complete. 
These experiments (Tables XVII., XVIII.) demonstrate the 
presence of coniplernent fixing antibody in the mouse-turnour antisera, 
and show a high degree of specificity, so that tlie reaction is much 
more evident with the honiologous antigen than with the extract of 
a different iiiouse tumour. The delicacy of the reaction is therefore 
such that it reveals differences between tumours, even from the same 
animal species, by quantitative differences in the power of aqueous 
extracts to fix coniplenient in presence of tlie corresponding antisera. 
This delicacy is stiikingly brought out in experiments with the 
serum against inowe tuunours grown in baby rats. 
TABLE XIX.--CoiiiLIeiiient Fixation liy ifPouse Sanoma (37 p qrown i n  Baby 
Rats) Anfise~um, mtlL Hoiitologous and Heterologous Antigens. 
1 .  . 
, 2 .  . 
i 3 .  . 
. 4 .  . 
I 
1 5 .  . 
6 .  . 
1 7 .  . 
\ 37p ( h 1 1  Baby ~ 
1 Eat) Antiserum. , Extract, 0'2 c.c 
Homologous 
I 
-i . I 0'1 
. ~ 0.05 
0.025 
0'01 
0.005 
0.0025 
- 1  
* I  
: j 0'001 
' Kone. 
i 
Slight. 1 
l hlarked. 
37 p (from 
Mouse) Extract, 
0.2 C.C. 
Trace. 
Slight. 
Marked. 
Nearly conipletr 
I 
199 Extract, 
0.2 C.C. 
None. 
Trace. 
Slight. 
Marked. 
Nearly complete 
Complete. ~ Complete. 
As Table XIX. shows, the antiseruni from mouse sarcoma 37p 
grown in young rats, in combination with extract of mouse carcinoma 
199 as well as of niouse sarconia 37p grown in mice, fixes comple- 
ment very feebly, whereas with the homologous antigen (extract of 
37p g o w n  in rats) the reaction is very striking. It is difficult to 
determine what significance should be attached to this result, which 
seems to indicate profound biological changes in the mouse sarcoma as 
a result of sojourn in the rat. The researches of J. B. Murphy 
(1914 *) and of W. E. Bullock (1915 3), however, show that the 
restrictions to the success of heterologous transplantation cannot be 
overcome even by a prolonged sojourn by repeated inoculation of a 
mouse turnour in alien organisnis (chick or rat), nor do mouse tumours 
after such an  interlude show any acquired disability of proliferation 
when returned to the maternal soil. 
Normal tissues of the mouse and rat can replace tumour tissue in 
ttie production of homologous cancer immunity. It is of interest to 
ascertain the behaviour of watery extracts of such tissues when 
employed as antigens for complement fixation with heterologous 
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199 Antiserum. 
__ 
0'1 
0'05 
0'025 
0'01 
0.005 
0.0025 
0.001 
mouse-tumour immune sera. For this purpose extracts were 
prepared of mouse liver and mouse embryo skin, and the reaction 
carried out with them (Tables XX., XXI.). 
Homologous 
Extract, 
0'2 C.C. 
__~_ .  .~ 
None. 
f ,  
,, 
, " 
Slight. 
,, 
Nearly complete, 
TABLE XX.-Complement Pixation by J4ouse Carcinoma (199) Antiserum, 
with Homologous Antigen and Extracts from Normal Mouse Liver and 
Mouse Embryo Skin. 
Homologow 
Extract, 
0'2 C.C. 
1. . . 
2. . . 
3 .  . . 
4 .  . . 
5. . . 
6 .  . . 
7 .  . . 
Mouse Embryo 
Skin Extract, 
0'2 C.C. 
-. - 
1 .  . . 
2 .  . . 
Mouse Embryo 
Skin Extract, 
0.2 C.C. 
- 
0 '1 
0'05 
None. 
Trace. 
Slight. 
Marked. 
Complete. 
,, 
I ,  
Slight. 
Mouse Lil 
Extract, 
0'2 C.C. 
Marked. 
Complete. 
Trace. 
Slight. 
Nearly com' 
Complete. 
,, 
TABLE XXI.-Complement Fixation by Mouse Sarcoma (31 s) Antiserum, 
with HO?nOlOgOU8 Antigen and Extracts from Normal Mouse Liver and 
Mouse Embryo Skin. 
37 5 Antiserum. 
3 .  . . 
4 .  . . 
5 .  . . 
0.025 
0'01 
0.005 
6 .  . . 0.0025 
1 7 .  . . I  0'001 Complete. 1 ,  
Mouse Liver 
Extract, 
0'2 C.C. 
_.__-__ 
Slight. 
Marked. 
Complete. 
,, 
> f  
9 ,  
1 9  
As before, the reaction with homologous antigen was very 
energetic, whereas only a feeble effect could be obtained with the 
normal tissue antigens. It is to be noted, however, that the embryo 
skin extract fixed ' complement rather more strongly than that from 
liver, a result which is of interest because embryo skin elicits a higher 
degree of homologoua resistance than any other normal tissue. 
In so far as conclusions can be drawn from complement fixation 
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as to the chemical constitution of the reacting substances, these 
experiments indicate chemical differences between normal and tumour 
tissues, and even between the different tumours of the same animal 
species. These differences probably involve the protein and lipoid 
constituents of the tissues, and for the latter there is already evidence 
of quantitative and qualitative differences in the work of Bullock and 
Cramer (1913 "). These authors investigated the lipoids of trans- 
plantable turnours of the mouse and rat. They found qualitative and 
quantitative differences in the distribution of the lipoid constituents, 
not only between tumours arising in different tissues, such as 
carcinomata and sarcomata, but also, though to a lesser degree, 
between different tumours derived from the same mother tissue, 
namely, a slowly growing and a rapidly growing mammary carcinoma. 
Confirmatory results were obtained when the mouse-tumour anti- 
sera were tested with extracts of rat tumours, and, conversely, rat- 
tumour antisera with mouse-tumour extracts. 
TABLE XXII.-Complement Fixation by Mouse Carcinoma (199) Antiserum, 
with Homologous and Eat Sarcoma (R 16) Extracts as Antigen. 
1 Homologous 
199 Antiserum. ~ Extract, 
I 
0'2 P.C. 
I 
1 .  . . 
2 .  . . 
3 .  . . 
4 .  . . 
5 .  . . 
None. 
I 
0.1 
0'05 
0'025 >, 
0'01 
0'005 
I , 
I > >  
1 
6 .  , . 0'0025 Slight. 
I i .  . . 0'01 Marked. 
R 16 Extract, 
0'2 C.C. 
None. 
,, 
Slight. 
Nearly complete 
Complete. 
i >  
,, 
TABLE XXII1.-Complement Pixation by Mouse Sarcoma (37 s) Antiserum, 
with Homologous and Rat Sarcoma (R IS) Extracts as Antigen. 
1 .  . . 
2 .  . . 
3 .  . . 
4 .  . . 
/ 
I 
Homologous 
37s Antiserum' Extract, 0:2 C.C. 
0'1 
0.05 
0'025 
0'01 
0'005 
0.0025 
0.001 
None. 
1 ,  
9 ,  
I, 
Slight. 
Marked. 
Nearly complete 
I R 16 Extract, ' 
0.2 C.C. , 
None. 
Trace. 
Slight. 
Nearly complete 
Complete. 
,f 
, 
_ _  - 
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TABLE XXIV.-Complement Fixation by Mouse Sarcoma (37 p grown ilz 
Baby Rats) Antiserum, with Honr.ologous and Rat Sarcoma (R 16) 
Xxtracts as Antigen. 
- 
~ 3 i p  (from Bi 
~ Rat) Antiseri 
I 
~ 
1 .  . - I - - -  . 0 '1 
2 . . . , 0-05 
3 .  . . 0.025 
4 .  . . 0.01 
5 .  . . ' 0.005 
6 . . . , 0.0025 
7 .  . . j 0'001 
Homologous 
Extract, 0.2 c.e. 
None. 
7 ,  
,, 
9 ,  
Slight. 
,, 
Marked. 
R 16 Extract, 
0'2 C.C. 
None. 
7 9  
I >  
Slight. 
Marked. 
Nearly complete 
Complete. 
Tables XXII., XXIII., XXIV. show much feebler complement 
fixation by rat-tumour extract with mouse carcinoma 199 and sarcoma 
37p antisera, than with the homologous antigem. The position is 
reversed when the same antigens react with the rat sarcoma anti- 
serum. 
TABLE XXV.--Contplement Fixation by Rat Sarcoma (R 16) Antiserum, with 
Homologous (199 and 37 p) Extracts as Antigen. 
-~ 
~. ~- . 
1 .  . . 
2 .  . . 
3 .  . . 
4 .  . . 
5 .  . . 
6 .  . . 
7 .  . . 
~~ ~ 
The rat 
_____ 
R 16 Antiserum. 
.- - 
0'1 
0.05 
0'025 
0'01 
0.005 
0'0025 
0.001 
antigen with 
Homologous 
Extract, 0.2 C.C. 
-~~ - ~~-  
None. 
, Y  
>, 
9 ,  
Trace. 
Slight. 
Nearly complete 
I99 Extract, 
0'2 C.C. 
Trace. 
Slight. 
,, 
Marked. 
Complete. 
I ,  
37 p Extract, 
0'2 C.C. 
Slight. 
&I arked. 
Complete. 
, I  
rat antiserum gives a strong fixation, the 
mouse-tumour antigens a very weak fixation (Table XXV.). 
It is rather remarkable that the absolute degree of the differences 
between homologous and strange antigen is much the same whether 
the experiment refers to two antigens from the same animal or 
whether they differ specifically as mouse and rat. It was therefore 
of interest to test the mouse-turnour antisera against tumour extract 
238 M TSURUMI. 
I 
ig9 ' Homologous 
Antiserum. Extract, 0.2 C.C. 
from a still more distantly related species, and for this purpose antigens 
were prepared from two human rnamniary carcinomata, supplied for the 
purpose by the courtesy of the Director of the Cancer Research 
Institute of the Middlesex Hospital, Dr. Lazarus-Barlow. One of the 
tumours was a relatively soft adeno-carcinoma, the other a scirrhus 
carcinoma. The extracts were prepared in the manner already 
described, and the dose was the same as in the other experiments, 
namely, 0.2 C.C. Three times the testing dose did not deviate comple- 
ment. In  the absence of normal human tissue, from which to prepare 
an extract, normal human serum from my own arm vein was used as 
control. The serum was inactivated, diIuted 1 in 1 0 ,  and 0.5 C.C. 
taken as antigen. Even 0.1 C.C. of the undiluted inactivated human 
serum did not give the slightest fixation of complement (Tables 
Human cancer extracts, therefore, give definite evidence of com- 
plement fixation with mouse- and rat-tumour antisera, rather more 
strongly with rat antiserum than with mouse. The indication of the 
probability of tumours from different species having some constituents 
a t  least in coinmon is interesting. Normal human serum, on the 
contrary, was practically inert. A similar result had already been 
recorded by Fleischmmn and Davidsohn (1 90 8 24), who found that 
the serum of a rabbit immunised against guinea-pig liver exhibited 
complement fixation in the presence of guinea-pig liver extract, 
whereas no reaction took place with guinea-pig serum. The com- 
bination, normal rabbit serum and guinea-pig liver extract, was also 
inactive. 
XXVI., XXVII., XXVIII.). 
Normal Human Human ' Human 
Serum, 0.5 C.C. Cancer 
(diluted I (A) Extract, 
TABLE XXVI.-Complement Fixation by Mouse Carcinoma (199) Antiserum, 
with Homologous Extract, Human Cancer Extracts, and Normal Human 
Serum. 
1 .  . . 
2 .  . . 
3 .  . . 
4 .  . . 
5 .  . . 
6 .  . . 
7 .  . . 
! _ _ _ _  __ 
0*1 None. 
0.05 ,, 
I 
0'025 ,> 
0.01 
0.005 Slight. 
0'0025 Marked. 
0.001 Nearly complete. 
I 
1 
I 
~- _____ 
Marked. None. 
Complete. ~ ,, 
,> Trace. 
,, Slight. 
,, I Marked. 
I 
1 
1 
I )  
, 
Cancer 
S) Extract, 
0'2 C.C. 
~ .. - 
None. 
Trace. 
Slight. 
Marked. 
Complete. 
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0'005 
0'0025 
1 .  . . 
2 .  . . 
3 .  . . 
4 .  . . 
5 .  . . 
6 .  . . 
7 .  . . 
Marked. 
Complete. 
37 8 
Antiseriiiii. 
0 .1  
0'05 
0 '025 
0'01 
Hoiuologous 
Estrwt. 0.2 v.c 
Xorie. 
Sligli t. 
Xioriiial Huniaii 
Seruiii, 0'5 C.C. 
(diluted 
tcii times). 
IIuiilaii 
Caucer 
A )  Estravt, 
0 .2  C.C. 
None. 
Trace. 
Slight. 
"1rkcd. 
Complete. 
Noiie. 
Slight. 
XarkaR. 
Coiiiplete. 
1 .  . . 
2 .  . . 
3 .  . . 
1 .  . . 
5 .  . . 
3 .  . . 
I .  . . 
R 16 Antiserum. 
0'1 
0.05 
0'025 
0'01 
0.005 
0'0025 
0'001 
Homologous 
Extract. 0'2 C.C. 
Now. 
TrU!e. 
Slight. 
h'carly ctrmplete 
K O 1  lllal Hllrllall 
Seruiii, 0'5 C.C. 
(diluted 
ten times). 
Marked. 
Coniplete. 
,> 
I ?  
IIuiiian Cancer 
( A )  Extract, 
0'2 C.C. 
Son(.. 
Slight. 
Marked. 
Coniplete. 
Complcnierit fixation is said to have been obtained with the seruni 
of cancer patients in some cases, using lecithin as antigen in the same 
way as has been found possible in the Wasseruiann reaction for 
syphilis. An experiment was performed to see whether the rabbit 
immune sera, now under consideration would fix complement in the 
presence of lecithin emulsions. The testing dose employed was 0.5 c. c. 
of a 0.1 per cent. watery suspensioi;, 1 C.C. of the suspension producing 
110 inhibition (Table XXIS.). 
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0'1 
0'05 
0'025 
0'01 
0.005 
0.0025 
0'001 
TABLE SSIY.--Ctmplement Fixation by Mouse Carcinonza (63) Antiserm~, 
zuith Lecithin as Antigen. 
~- -~ ~- ~ - 
Slight. 
Complete. 
> >  
,, 
,, 
1, 
l . . .  
2 .  . .  
3 . . .  
4 . . .  
5 . . .  
6 . . .  
7 . . .  
Lecithiii, 
(37p) 0.1 per 
Serum. cent., 
0.5 C.C. 
- _ -  
0 '1 Conipletr. 
0.05 
0.025 
0.01 ,? 
0'005 9 ,  
0.0025 ,, 
0'001 > 
(63 in 
Baby Rat) 
Sernm. 
0'1 
0'05 
0'026 
0'01 
0.008 
0'0025 
I 
0'001 1 
Lccitliin, 
0'1 per 
ceiit., 
0.5 C.C. 1 
- I  
Complete. 
,, ' 
,, 
1 ,  
With t w o  of the antisera no fixation took place, and with the third 
serum tested only the faintest inhibition was obtained. As is well 
known, lecithin undergoes changes with age, and in this case the lecithin 
used was not above suspicion. 
Xunanza yy. 
1. Complement fixing antibodies are present in the immune sera 
obtained by immunising rabbits with mouse and rat tumours. 
2. I n  every case the reaction was most strongly positive when the 
homologous antigen was used ; it was feeble with other antigens even 
when these were prepared from similar tumours from the same 
species. 
3. Antigens prepared from normal tissues of the mouse and rat 
reacted only feebly with the immune sera prepared against the tuinours 
of the same animals. 
4. Tumour extracts from alien species gave distinct complement 
fixation with the mouse- and rat-tumour antisera. In particular the 
rat-tumour antiserum fixed complement strongly with extract of 
human cancer. 
5 .  When lecithin emulsion was used as antigen the reaction was 
negative (in one case feebly positive). 
Normal human serum was practically inactive. 
V. PBECIPITIN REACTION. 
The majority of the numerous references to the precipitin reaction 
in cancer concern themselves with attempts to utilise the method for 
serum diagnostic purposes in man and animals bearing tumours. It is 
unnecessary to refer to these studies in detail, as they have little eon- 
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iiectiou with the present investigation, which is restricted to tlie in- 
vestigation of the  precipitating properties of heterologous inmiiine 
cancer sera. Even in this restricted dornuin much work has been 
done, arid s o u e  authors claim a diagnostic value for the method, while 
others have come to the  conclusion that the  reaction is not specific. 
Engel (1 903 56) imniunised rabbits by intraperitoneal injection of inactivated 
wrum from two cancer patients. The immune serum thus obtained was pre- 
cipitated by the sera of the cancer patients, but only feebly by the sera of other 
patients ( anax~ ia ,  epilepsy, nephritis). 3Laragliano (1901 27) imniunised rabbik 
with the gastric juice of patients with carcinoma of the stomach. The immune 
serum gave the reaction with the gastric juice of other cases of stomach cancer. 
Later, Seratini and Diez (190825) continued these observations on a number of 
cases, obtaining positive results in cases of stomach cancer, and negative results 
with the gastric juice from other petients with etomach diseases. Kullmann 
(1 904 2)) immunised the animals with tumour extract. The antiserum obtained, 
however, showed an equally strong precipitin reaction with normal as with 
cancer serum. Ranzi (190830) repeated thew experiments on a large scale, 
using extracts of carcinoma and sarcoma. The antiserum obtained was not 
specific, as there was no difference in the reaction when homologous antigen 
and other organ extracta or normal hunian serum were employed. Romkes 
(1903 31), hornever, claimed good resultJ with the method. 
The purpose of the  present investigation was to determine whether 
the  iumune  sera against mouse and rat turnours were precipitated in 
a specitic manner by their hornologous antigens, r? subject which 
apparently had not been previously studied. 
Methods. 
Tlie iinmuiie sera used for the precipitin reaction were not inactivated, 
control experiIiients having shown that inactivatioii made no difference to the 
reaction. The extracts employed as precipitinogen were the same as those 
which served for complement fixation. The concentrations and doses used will 
he describetl later. The chemical reaction of the extracts was acid from the 
presence of 0.5 per cent. carbolic acid in the saline used to make the extracts. 
The duration of incubation has a great influence on the results of the reaction, 
and in tliere experiments the result was read after a uniform interval of 
twenty-four hours, while the examination of the tubes after a few hours showed 
no change. 
The successive dilutions of the immune sera were prepared in the following 
manner. Tlie serum was diluted 1 : 10 in normal saline, arid 1 C.C. of this 
diluted serum placed in the first two tubes. To each of the tubes, except the 
first, 1 C.C. of normal saline was added. From the second tube, after thorougll 
mixing, 1 C.C. of fluid was withdrawn by a pipette and transferred to the third 
tube. Thus a series 
of tribes was obtained containing serum 1 : 10, I : 20, 1 : 40, 1 : 80. Lastly, to 
each tube 1 C.C. of tumour extract was added, tlie final concentration of anti- 
serum in c:ich tube being 1 : 30, 1 : 40, 1 : 80, etc. 
This in turn was well mired and the process repeated. 
h’xpe?imental Obsewatiotu. 
In the  first instance, 1 C.C. of the  undiluted extract (1 : 6 )  was used 
So reaction took place even with homologous as the  testing dose. 
antiserum. From a consideration of tlhe peculiarities of precipitin re- 
actions generally, this failure might be due to unsuitable conditions as 
to concentration, reaction, OY temperature. Before proceeding to altera- 
tions in reaction and temperature, alterations in concentration of the 
extracts were tried in order to find the optimum concentration. For 
this purpose falling doses of extract were added to 0.1 C.C. of anti- 
seruiii (Table XXX.). 
TAnm SSX- The Optimunl Concentrataon qf A1fou~e-%tiou?' 
Erf rncts f o r  Precipitin Reaction. 
Ten times diluted 
1 C.C. 
j 199 Estract. ' Soilialogous Serum. 
- ~. I 
I 
1 .  . It 5 Y  111 1 C.C. 
1 2  . . . . ' l O S , ,  ,, - 
3 . . . . ' Z O X , ,  ,, 5 
4 . . . . , 4 o s , ,  > )  1 , + +  : 
. 80.u ,, ,, + +  
1 .  . . 
2 .  . . 
3 .  . . 
4 .  . . 
5 .  . . 
. I  
37p (from Babj Rat) 
Extract. 
5 x in 1 C . C .  
~~ ~~ . 
lox ,, >, 
2os, ,  ,, 
4ox ,, ,, 
S O X  >, :, 
i - 
+ +  I + + +  
I +  
The tables demonstrate that with dilutions higher than tenfold, pre- 
cipitation sets in with the homologous antiserum, and the optimum 
concentration lies between the forty-fold an$ eighty-fold dilution of 
each extract. In these experiments, also, the tubes were maintained 
a t  37" C. for twenty-four hours before the results were noted. Kelling 
(1 9 0 7 32) also found that high dilutions of precipitinogen (1 : 1 0  0 0 or 
1 : 2000) gave better results. It was of interest to know whether the 
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percentage protein content of the watery extracts showed constant 
differences between the several extracts. For this purpose Esbach's 
alburninometer was used, the extracts being diluted twenty times with 
normal saline containing 0.5 per cent. carbolic acid (Table XXXI.). 
TABLE XXX1.-Protein Contents in Various Turnours and Organ Extracts. 
1. Mouse carcinoma (63) extract 
3. Mouse sarcoma (37p) ), 
5. 9 ,  (37p) (from baby rat) extract . 
6. Rat sarcoma (R 16) extract. 
7. Human cancer (adeno-carcinoma) extract (A) 
8. ,, (scirrhus) extract (S) . 
9. Mouse embryo skin extract 
. 
2. 7 )  (199) 1, 
4. ,, (378) 1 ,  
. 
10. Mouse liver extract. 
11. Rat liver extract . 
Over 1 per cent. 
About 1 ,, 
Just  1 ,, 
, I  0.5 ,, 
About 1 ,, 
,, 1.2 I ,  
Just 1 ,, 
About 0.5 ,, 
,, 0.8 , I  
Jnst 0.5 ,, 
,, 0.5 ,, 
NoTE.-Extracts were diluted twenty times with saline. 
The protein content varied from 0.5 per cent. to 1 per cent. No 
special difference could be found between the extracts from normal 
tissues and tumours or between the tumours themselves. The protein 
content in the testing dose which was suitable comes out a t  about 
1 : 2000, which agrees with Kelling's results. In  spite of these pre- 
cautions the precipitin reaction with tumour immune sera did not give 
very conclusive results. 
TABLE XXXIL-F'recipitin Reaction by Mouse Sarcoma (37 s) Antiserum, 
with Homologous and Heterologous Xxtracts. 
1 . .  . 
2 . .  . 
3 . .  . 
4 . .  . 
1 . .  . 
2 . .  . 
3 . .  . 
4 . .  . 
1 . .  . 
2 . .  . 
3 . .  . 
4 . .  . 
91 I Antiserum. 1 Absolute Dilution. Honiologous Extract, 1 C.C. 
f + f  
+ 
5 
- 
1'39 Extrabt, 1 C.C. 
- 
- 
- 
- 
R 16 Extract. 1 C.C. 
l o x  in 1 C.C. - 
2 o x , ,  I ,  4 0 x  ' - 
4ox ,. ., 80 x 
8 0 x  ,, ,, I 160X - 
As Tables XXXII., XXXIII., XXXIV. show, the reaction although 
not very strong was definitely specific, the homologous extract in every 
case reacting more strongly than the others. This specificity is still 
more marked when human cancer extracts react with the mouse- 
tumour antisera, no precipitation taking place (Tables XXXV., 
x x x v r . > .  
TABLE XXXIII.-Precipitin Reaction h y  Mouse Cawinonza (199) 
Antiserum, with Homologous and Heteroloyous Extracfs. 
1 . .  
2 . .  
3 . .  
4 . .  
1 . .  
2 . .  
3 . .  
4 . .  
1 . .  
2 . .  
3 . .  
4 . .  
I 
199 Antiserurn. 
I 
. ~ 2ox ,. ,. 
. 1 40x ,, ,, 
. 1 80x ,, ,, 
Di,otion. Homologous Extra(::. 
1 C.C. 
~ - ~- 
20 x 
40 x 
80 s 
160 s 
~. - 
20 x 
40 x 
80 s 
160 Y 
. lox in 1 C . C .  20 s 
. 20 x ,, 1 .  40 S 
. 4 o x , ,  ,, 80 s 
. ' sox ,, ,, 1 1 6 0 ~  
I 
37 p Extrsrt, 1 C.C. 
+ i- 
+ 
I R 16 Estract, 1 C.C. 
+ -1 i -  
The rat-sarcoma antiserum shows much the same state of affairs, 
reacting strongly with the rat-tumour extract, but not a t  all with those 
from mouse tuniours. Human cancer extracts behave in an anomalous 
manner, giving as strong a reaction as the homologous rat-tumour 
extract (Table XXXVIT.). 
h5tninial.y. 
The precipitin reaction with mouse- and rat-tumour antisera whiIe 
Although quite specific in the quite definite was not very strong. 
iiiajority of cases, there were notable exceptions. 
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2 . . . . 
3 . . . 
j 4 . . . 
! 
I 
- 1  . 
1 2  ' 
1 3  . 
4 .  
~ 
1 .  
2 .  
3 .  
I 
l 4  . 
2 0 x  ,, ,) 
80x ,) ,, 
40x ,, ,, 
TABLE XXXIV.-Precipit in Reaction by Mouse Sarcoma (37 p poton i n  
Baby Rats) Antiserum, with Homologous and Heterologous Extracts. 
199 Absolute 
Antiserum. I Dilntiori. 
I 
. .  
. .  
. .  
. .  
I 
1 Human Htiman 
Homologous 1 Cancer Cancer 
Extract ,  1 C.C. (A)  Extract, (S) Extract, 
1 C.C. 1 C.C. 
i 1  . 
. .  
. .  
. .  
. .  
i Homologous Extract, I 1 C.C. 
I I 
I + + +  
I + +  + I 
1 R16 Extract. 1 C.C. 1 
j l  . . 
~ 2 . . . ' 2 0 x , ,  ), 
I 
3 . . . I 40s ,, ,, 
4 . . . s o x  ,, ,) 
189 Extract, 1 C.C. 1 - 20 x 40 x 
80 x 
160 x 
- 
- I 
I 
1 - 31 p (from Mouse) 
Eutrsct. 1 C.C. 
20 x 
40 x 
- 
- 
I 
- 
- 80 x 
160 s 
TABLE XXXV.--Prec@itin Reaction by Mouse Carcinonia (199) Antiserum, 
with Honzoloqous and Human Cunces- Extracts. 
20 x + + +  1 - I 
1 
- 
- 
+ - 
I 
+ +  i I 2 .  . . 2 0 s  3 .  . . 40s 80 x 4 .  . . 80x 160 x 
17-~1.. OF PhTII.-VOId. SS. 
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TABLE XXXVL-Precipitin Reaction by Mouse Sarcoma (37 s) Antiserum, 
ruith Homologous and Human Cancer Xxtracts. 
37 8 Absolute 
Antiserum. Dilution. 
__ ~ 
1 .  . . 10s ' 20 x 
2 .  . . 2 0 s  40 Y 
3 .  . . 4 0 x  sox 
4 .  . . 80s 160 x 
~ Homologous 
i Extract, 1 C.C.  
1 Human 
1 Cancer 
! (A) Extract, 
i 1 c.c. 
I + + s  
1 
Human 
Cancer 
(S) Extract, 
1 C.C.  
I 
I 
- - 1  
i 
TABLE XXXVI1.- Precipitin Reaction by Rat Sarcoma (R 16) Antiserum, 
with Homologous and Heterologous Eztraets. 
___ 
1 .  
2 .  
3 .  
4 .  
R 16 
An ti serum. 
10 x 
20 x 
40 x 
80 x 
Human 
Absolnte H $ ~ ~ ~ ~ ~ s  Cancer 199 Extract, 
Dilution. (A) Extract, I 1 0 C.C. 
c*c. ~ 1.0 C.C. I 
so x + + 
I 
160 x 
L7p Extract, 
1'0 C.C. 
VI. CYTOLYSIS. 
Used in a wide sense, cytolysis may be held to include hzmolysis, 
and one would expect that the antisera to mouse tumours which have 
been shown to be strongly hzemolytic for mouse corpuscles, would also 
produce lysis of mouse-tumour cells. In view of the hzemolytic 
strength of these antisera, it was anticipated that the demonstration 
of cytolysins for tumour-cell emuIsions would present no difficulty. 
The discovery and application of bacteriolytic antisera to the treatment of 
infectious diseases has induced many workers to attempt an analogous solution 
of the problem of a rational cancer therapy. Investigations in this direction 
start from the discovery by v. Dungern (189933) of an epitheliolysin for 
ciliated epithelium in the serum of rabbits immunised with the tracheal 
epithelium of the ox, and by Metchnikoff (1900 35) of a spermotoxin obtained 
by injecting guinea-pigs with emulsions of rabbit testicle. A. v. Wassermann 
(1912 33) mentions, in tho introduction to his paper on cancer chemotherapy, 
unsuccessful experiments carried out in collaboration with Eorchardt in v. 
Bergmann's clinic with the serum and milk of goats immunised against 
human mammary cancer. No effect was produced 011 the course of the disease. 
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Lambert and Hanes (1911 3fi) found that mouse and rat sarcomata, which grow 
well in ci ty0 in the normal plasma of alien species, do not grow at all in the 
plasma of animals of such species after they had been immunised against 
these tumours of the mouse or rat. They ascribed this failure to  presence of 
cytotoxins in the plasma of the ininiunised animals. 
The present attempt was carried out by applying the ordinary 
methods used for bacteriolysis. KO siiccess was obtained, but it may be 
as well to describe the experiments for the benefit of other workers. The 
immune sera against mouse carcinoma 199 and mouse sarcoma 37p 
were inactivated by heating at  56" C. forkhalf an hour. To 1 C.C. of 
each serum 0.5 e.c. of the respective tumour emulsions, very finely 
divided, was added. Coinplement, 0.5 C.C. of fresh guinea-pig serum, 
was added, and the whole placed in the incubator a t  37" C. for three 
hours. At  the end of this interval the serum was removed and the 
turnour emulsion inoculated into n dozen mice. The following controls 
were inoculated at  the same time : 
1. Untreated emulsion. 
2. Emulsion incubated for three hours a t  37" C. with inactivated 
3. Emulsion incubated for three hours a t  37" C. with complement 
No differences could be observed in the number or rate of growth 
immune serum only. 
only. 
of the turnours obtained. 
VII. OTHER EXPERIMENTS. 
I. Xozcse-tumour extract ccin replace intccct tzinzour cells as antigeiL 
f o r  heterologous immunity. - Haaland (1 9 1 0  ") showed that intact 
living normal or tumour cells were indispensable to induce homologous 
resistance to transplanted mouse carcinomata. I t  was immaterial in 
what way the cells were killed, whether by mechanical disintegration, 
by heat, or by exposure to radium in the ice-chest, the power to 
produce resistance was annihilated along with the power of growth. 
A rabbit 
was injected intraperitoneally with 5 C.C. of a watery extract from 
1 C.C. of an emulsion of mouse sarcoma 37p. After an appropriate 
interval the rabbit was bled and the serum examined for the presence 
of hemolysins for mouse corpuscles (Table XXXVIIT.). 
The experiment shows clearly that the watery extract is sufficient 
to give rise to the specific hemolysin, and the same result was obtained 
by using disintegrated tumour cells. The serum also gave a positive 
result when tested for hEmagglutination and complement fixation. 
Whatever may be the cell constituent of mouse tumours which acts as 
lysinogen, it is soluble in water or a t  any rate paeses into the watery 
extract, as Takaki (1908 38) showed for the lysinogen of red blood 
corpuscles. Bulloch (1 9 13  37) demonstrated that extraction with ether 
The case of heterologous resistance is quite different. 
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for six hours robbed erythrocytes of their power to produce hzmolysins, 
but a similar esperinient has unfortunately not yet been perfornied 
with niouse and rat tuniours. The experiments, therefore, do not 
decide the nature of the lysinogen concerned. 
TABLE XXXVIII.-Hcemolytic Reaction by Rabbit Serum M A  ich KUS ohtained 
by inzn~unisici?ig against TVafery Extract of Mouse Sareonaa (37 p). 
Serum. Guinea-pig Complement, 0'05 C.C. 
I 
I 
-~ - .  ~~~~ 
0'1 Complete. 
0.05 Nearly coniplete. 
* I  
1 .  . . 
1 
2 .  . . 
. I 0.028 Slight. . /  3 .  . . 
4 . ,  . . 0'01 Traw.  
' 5 .  . . . 0.005 None. 
~ 
11. AIozise enzbmjo uiw&oii as antigen fo1- hetero~o~qoirs imnud$.- 
The great activity of mouse enibryo emulsions in eliciting homologous 
resistance naturally raises the question of its suitability as antigen for 
heterologous immunity. The complement fisation experiments with 
mouse embryo skin extract as antigen showed great apparent differences 
between mouse tumour and mouse embryo skin, and i t  was therefore 
decided to obtain an antiserum to mouse embryo. A rabbit was 
immunised intraperitoneally with three ascending doses of niouee 
embryo, 1 c.c., 3 c.c., and 4 c.c., a t  intervals of one week. Ten djys  
after the last injection the seruni was collected and tested for the 
presence of hamolysins (Table XXXIX.). 
TABLE XXXIX-Ho molyti(. Reaction b y  Babliit Serum obtained by 
irmnunisiwg ngnz mf Jfouse E t n b r ~ ~ o  Skin. 
~ ~~ ~- ~ 
I ElAJOD COllPU%I,l \. I 
~ - - .~ .... 
1 . .  . . 
1 4 .  . . . 
5 . .  . . 
-. .. - -. . 
Guinea-pig Coniplenicnt, 
0.05 C . C .  
~~ ~- 
Complete. 
iSearl y complete. 
Sllgllt. 
Tiscc,. 
Kone. 
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The homolytic action is quite evident, as was to be expected. The 
serum of mice, on the other hand, inoculated three times at  intervals 
of one week with 0.05 C.C. of mouse embryo skin does not prodwe 
h;~niolysis of mouse erythrocytes. Similar bzmolytic and coniplenient 
fixation experiments with the seruui of mice in which transplanted 
tumours had grown and been absorbed were equally negative. I n  this 
respect, also, the sharp distinction between homologous and hetero- 
logous immunity is very evident. 
111. Hcernolysis of mouse wythroeptes with the  seywm of rats in which 
7noicse tzimour had grown and been absorbed.-The rapid and coniplete 
disintegration of mouse-tumour grafts in rats in which mouse tumours 
had grown and been absorbed has been ascribed to the development 
of antibodies to mouse tissue in the rat. The serum of young rats in 
which mouse sarcoma 37p had grown temporarily was taken as soon 
as absorption was complete and tested for heinolysis of mouse red 
blood corpuscles (Table SL.). 
TABLE XL.-Hccvnolytic Reaction with S e r u m  of B a b y  Rats in which Mouse 
Sarcoma (37 p> developed and afterwards was absorbed. 
I 
I MOUSE BLOOD COFPUSCLE~. 
Serum. 1 Guinea-pig Complement, 0'05 C.O. 1 
0 '1 
0.05 
Trace. 
I 1 3 .  . . 0'025 I None. 
1 4  . . i I 
The reaction was so faint that it cannot properly be described as 
positive. It is probable that this result is in part due t o  the immature 
state of the rats, and in part to the fact that only one injection of 
turnour was given, both of which conditions are unfavourable to the 
production of a potent antiserum. The interval after inoculation may 
also have been too prolonged. 
CONCLUSIONS. 
The malignant new growths of man and animals, under a great 
diversity of anatomical forms, aye united loosely together by a number 
of characters coninion to  all. While it is comparatively easy, as well 
as a descriptive convenience, to distribute them into the main sub- 
divisions of carcinoma and sarcoma and their subsidiary histological 
groups, this method of examination by itself breaks down when the 
attempt is made to find morphological criteria which can be relied on 
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to separate the similar histological groups of different species and, 
still more, the similar tumours of the same species. The experimental 
study of transplantable tumours has elicited the fact that turnours, 
apparently structurally identical, may possess constant loiological 
characters which differentiate them completely from each other. The 
criterion of growth, again, usually suffices to separate the tumours 
belonging to different species from each other, tuniours being easily 
propagable in animals of the parent species, and failing to proliferate 
for any length of time in alien species. These and other differences 
have their counterpart in the serum reactions of which an account has 
been given. Although we are still far from a complete correlation of 
the results of these distinct methods of investigation, it is of interest 
to attempt a general survey arid to formulate provisional conclusions. 
These serum reactions, as was to be expected, are to a certain 
extent examples of the reactions characteristic for tissues of the 
species from which the antigens are derived, and show features which 
may be interpreted as due to blood-relationship. Due allowance must 
be made for these features before it is permissible to utilise the 
reactions for an analysis of the cliaracters of the tumours as tumours. 
In this respect the reactions fall natumlly into two groups: in t h e  
first, comprising hEuiolysis and hamagglutination, the reactions of 
uouse tumours pi id mouse tissue overshadow all minor differences : in 
the second group, comprising complement fixation and precipitins, the 
species characters are overlaid with the effects of other differences of 
a more individual kind enhancing the difficulties of interpretation but 
promising fresh insight into the biochemistry of malignant new 
growths. I n  the case of the hcernolysins it is found that the mouse- 
tuinour antisera are considerably more hzmolytic for mouse erythrocytes 
than for those of the nearly related rat. These antisera are practically 
without action when red blood corpuscles of the rabbit or guinea-piq 
are substituted for mouse or rat  corpuscles in the hcemolytic system. 
The rat-tumour antiserum, equally inactive on rabbit and guinea-pig 
corpuscles, is strongly hzmolytic for rat corpuscles, and only faintly 
hcemolytic for those of the mouse. The phenomena of hxmagglutina- 
tion show corresponding features. The antisera obtained by immunis- 
ing with mouse tumours grown in young rats show an intermediate 
condition. They are nearly equally hzemolytic (and agglutinative) for 
moiise and rat corpuscles, a condition in all probability due to the 
unavoidable intimate mixture of mouse parenchyma and rat stroma in 
the tuinour emulsions used as antigens, in this case. 
The hemolysin for goat erythrocytes present in the antisera against 
mouse and rat tuniours is a distinct antibody comparable to and 
probably identical with the hzmolysins discovered by Forssmann and 
Morgenroth in animals immunised with organ emulsions of the guiuea- 
pig and mouse. Morgenroth also found this goat hEmolysin in rabbits 
imrnunised with mouse tumours : with excessive caution he refrained 
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from identifying it with the hemolysins obtained by immunising with 
mouse kidney. There seems to be no valid reason for doubting their 
identity. This exception t o  the general specificity of hzmolysins has 
led to interesting speculations on the nature of the mother substance 
of specific hzmolysins, lysinogens, by Forssmann, Landsteiner, and 
others. Forssmann brought forward the view that the lysinogen 
would prove to be of a lipoid nature ; Landsteiner, that a combination 
of lipoid and protein corresponded more closely with the facts. It is 
unnecessary to discuss the matter further, as the present investigations 
do not permit of definite conclusions on this difficult question. 
The several antisera prepared with different mouse tumours agree 
closely in hzmolytic strength. A difference was noted between the 
antisera to carcinoma and sarcoma in that the strength of the sarcoma 
sera (of which two had been prepared with different sarcomata) was 
slightly greater than that of two carcinoma antisera. As far as  
possible the doses and intervals of immunisation were the same in all 
cases. The carcinoma antisera, on the other hand, were hemolytic 
when complemented with normal rabbit serum in a dose quite inactive 
with the sarcoma antisera. The difference, therefore, can hardly be 
purely quantitative. Apart from this the fresh sera of the mouse, rat, 
and rabbit were without action in the dose adopted when substituted 
for fresh guinea-pig serum as complement to these antisera. 
The most constant feature of the complement fixation experiments 
is the regularity and energy with which fixation occurs when the 
homologous extract is put in contact with an antiserum (Tables XLI., 
XLII.). The other extracts, whether from similar tumours of the 
same species or from tumours of other species, give a much weaker 
reaction. The evidence in this respect implies the possession of 
substances of importance in the reaction by each tumour strain, 
peculiar to itself. This is remarkable when it is remembered that the 
strains of mouse tumour employed have all been propagated for years 
in a succession of normal mice, and the tumours for immunisation 
came from one set of animals, those from which the extracts were 
prepared from another series. Nevertheless, the Bordet-Gengou 
reaction picks out the homologous extract in every case. There is 
here an exact counterpart to the phenomena of propagation, such as 
the persistence in individual tumour strains of characteristic features 
in the rate and percentage of growth, and also in histological 
structure. 
The extracts prepared from normal tissues turn out to be unex- 
pectedly weak in complement-fixing power, in many cases weaker even 
than extracts of tumours belonging to other species. This result may 
be due to differences between tuniour and normal tissues in the ease 
with which the reacting substances pass into the watery extracts, but 
in any case it points to essential differences between heterologous and 
homologous immunity, since i t  has been shown that in the latter case 
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31 P Rat, ' 31 p Mnnse, 
0-2 C.C. 0"' C.C. 
-_____ 
31 p (in Rat) 
Antiserum. 
100, 
0 2  C.C. 
- 
0'1 
0.05 
0.025 
0'01 
0'003 
0'0025 
0.001 
_____ ~. 
R 16 
Antisenim. 
0.1 
0'05 
0'025 
0.01 
0.005 
0.0028 
0'001 
Table XLII. 
Sone. Trace. 
,, ,, 
None. 
Trace. 
,, ,, I > >  
Slight. Marked. Marked. 
Nearly complete. Nearly conipletc. I 
Marked. Complete. 
3 16, 0.2 C.C. 198, 0'8 C.C. 
~ -~ 
Rone. Trace. 
3 ,  Slight. 
,, ' ,> 
Maiked. 
Ti ac0 Complete. 
Slight. I 
Nearly complete. ,, 
31 p. 
Slight. 
Marked. 
I 
Coiiiplete. 
R 16, 0'2 C.C. 
None. 
9 ,  
,$ 
Sligll t. 
Marked. 
Nearly complete 
Complete. 
Normal Human 
Serum, 0'5 C.C. 
(diluted ten 
time%). 1 
Human 
Cancer 
(A) ExLract, 
0.2 C.O. 
Marked. 
Complete. 
> >  ~ 
, 
' I  t ,  
None. 
I, 
I f  
,, 
Slight. 
Marked. 
Complete. 
normal tissues can elicit the immune or resistant condition as well 
as do tumour tissues. It is perhaps well to exercise caution in 
appraising the significance of the esperinients with extracts of other 
tumours whether of the same or other species. There is no clear 
evidence of a community of antigenic substances in the histological 
groups, since the sarcoma extracts, for example, do not react more 
strongly with the earcoma antisera than do the extracts of carcinomata. 
There is a further consideration which must be given considerable 
weight in this respect. As is well known, organ extracts can be 
replaced by artificial cholesterin-lecithin mixtures as antigen for the 
WRssermann reaction for syphilis. The physical state of these lipoid 
emulsions has a great influence on their suitability, so that slight 
changes in the mode of preparation abolish their complement-fixing 
properties completely. It is now fairly well established, however, that 
the cell lipoids of malignant new growths show significant variations 
in their relative proportions from one tumour strain to another, and 
may also differ from those present in normal tissues in a similar 
way. It may therefore well be that similarityin the state of physical 
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aggregation is largely responsible for the yesults obtained in com- 
plement fixation and precipitin experiments. There is apparently no 
correspondence with the other known characters of these growths, so 
that here a new set of independent properties is revealed. I t  remains 
for further investigation to determine whether the antigenic substances 
in the different tuniours from the swie and other species are t o  some 
extent common or closely related, as these experiments seem to show, 
and should this prove to be the case, the nature of the cell constituents 
involved. 
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